HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcello Moccia Selected Research

Marcello Moccia Research Topics

Disease

43Multiple Sclerosis
03/2024 - 01/2014
18Parkinson Disease (Parkinson's Disease)
12/2020 - 11/2012
8Cognitive Dysfunction
11/2023 - 02/2013
7Relapsing-Remitting Multiple Sclerosis
01/2022 - 01/2015
4COVID-19
01/2022 - 10/2020
4Inflammation (Inflammations)
11/2021 - 10/2017
3Infections
07/2022 - 10/2021
3Atrophy
07/2020 - 11/2019
3CADASIL
01/2018 - 01/2015
2Demyelinating Diseases (Demyelinating Disease)
11/2022 - 10/2017
2Pain (Aches)
10/2020 - 01/2019
2Progressive Multifocal Leukoencephalopathy
01/2017 - 01/2014
2Dementia (Dementias)
04/2016 - 05/2015
1Chronic Progressive Multiple Sclerosis
04/2024
1Lymphopenia (Lymphocytopenia)
11/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2023
1Congenital Abnormalities (Deformity)
01/2023
1Radiculopathy (Radiculopathy, Cervical)
11/2022
1Myelitis
11/2022
1Optic Neuritis (Retrobulbar Neuritis)
11/2022
1Neuromyelitis Optica (Devic's Disease)
11/2022
1Communicable Diseases (Infectious Diseases)
07/2022
1Sudden Infant Death (SID)
01/2022
1Ganglion Cysts (Ganglion)
12/2021
1Opportunistic Infections (Opportunistic Infection)
10/2021
1Muscular Diseases (Myopathy)
01/2021
1Diplopia (Double Vision)
01/2021
1Strabismus (Squint)
01/2021
1Neuromuscular Junction Diseases
01/2021
1Oculomotor Nerve Diseases (Oculomotor Nerve Palsy)
01/2021
1Nervous System Diseases (Neurological Disorders)
01/2020
1Fatigue
01/2019
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2015
1Infarction (Infarctions)
01/2015
1Parkinsonian Disorders (Parkinsonism)
01/2015
1Tremor (Tremors)
11/2014
1Hypokinesia (Bradykinesia)
11/2014
1Nocturia
08/2014

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
01/2020 - 02/2013
6Uric Acid (Urate)IBA
12/2016 - 07/2014
5ocrelizumabIBA
03/2024 - 04/2021
4Retinaldehyde (Retinal)IBA
01/2023 - 11/2018
4Natalizumab (Tysabri)FDA Link
01/2023 - 01/2014
4Monoclonal AntibodiesIBA
01/2023 - 01/2022
4AntibodiesIBA
11/2022 - 10/2020
4CladribineFDA LinkGeneric
02/2022 - 01/2020
3COVID-19 VaccinesIBA
11/2023 - 01/2022
3Interferon-betaIBA
01/2021 - 08/2015
3InterferonsIBA
01/2018 - 01/2015
3Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
05/2015 - 11/2012
2SphingosineIBA
11/2023 - 01/2022
2Fingolimod Hydrochloride (FTY720)FDA Link
11/2023 - 01/2023
2GadoliniumIBA
01/2023 - 02/2019
2Immunoglobulins (Immunoglobulin)IBA
01/2023 - 01/2022
2Rituximab (Mabthera)FDA Link
11/2022 - 04/2021
2Botulinum Toxins (Botulinum Toxin)IBA
11/2022 - 10/2020
2Interferon beta-1aFDA Link
11/2021 - 10/2017
2AntioxidantsIBA
11/2021 - 06/2016
2coenzyme Q10 (CoQ10)IBA
09/2019 - 01/2019
2Nonsense Codon (Nonsense Mutation)IBA
01/2015 - 01/2015
2SmokeIBA
01/2015 - 05/2014
1siponimodIBA
04/2024
1ozanimodIBA
11/2023
1Vitamin DFDA LinkGeneric
11/2023
1Dimethyl FumarateIBA
01/2023
1Myelin-Oligodendrocyte GlycoproteinIBA
11/2022
1AntigensIBA
07/2022
1Phosphates (Orthophosphate)IBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Neuroprotective AgentsIBA
11/2021
1CurcuminIBA
11/2021
1PhytochemicalsIBA
11/2021
1Alemtuzumab (Campath)FDA Link
10/2021
1Immunoglobulin G (IgG)IBA
12/2020
1Immunoglobulin M (IgM)IBA
12/2020
1Cytidine Diphosphate (CDP)IBA
07/2020
1nabiximols (Sativex)IBA
06/2020
1VS 215IBA
11/2019
1Atorvastatin (Lipitor)FDA Link
02/2019
1Notch3 ReceptorIBA
01/2018
12-toluenesulfonamide (OTS)IBA
08/2017
1Caffeine (No Doz)FDA LinkGeneric
11/2016
1BilirubinIBA
06/2016
1Vitamin KFDA Link
08/2015
1Cholecalciferol (Vitamin D3)FDA Link
08/2015
1Dopamine (Intropin)FDA LinkGeneric
05/2015
1Oxygen (Dioxygen)IBA
04/2015
1NitrogenIBA
04/2015
1Levodopa (L Dopa)FDA LinkGeneric
03/2015
1Cysteine (L-Cysteine)FDA Link
01/2015
1Proteins (Proteins, Gene)FDA Link
01/2015
12- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
11/2014
1C-Reactive ProteinIBA
01/2014
1ImmunosorbentsIBA
01/2014
1DNA (Deoxyribonucleic Acid)IBA
01/2014

Therapy/Procedure

9Therapeutics
11/2023 - 01/2013
2Injections
11/2022 - 05/2018
1Telescopes
01/2021
1Continuity of Patient Care
12/2020
1Activities of Daily Living (ADL)
10/2020